Novo Nordisk A/S (NVO) Stock Forecast and Price Target 2024

Novo Nordisk A/S (NVO) Stock Forecast And Price Target 2024

1 week from now

2 days ago  · Consensus Price Target. According to the 7 analysts' twelve-month price targets for Novo Nordisk A/S, the average price target is $144.50. The highest price target for NVO is $160.00, while the lowest price target for NVO is $115.00. The average price target represents …

marketbeat.com

What Is The Current Price Target And Forecast For Novo Nordisk …

1 week from now

5 days ago  · The current on short-term price targets is based on 4 reports. The forecasts for Novo Nordisk A/S (NVO) range from a low of $85.5 to a high of $160. The average price target …

zacks.com

Novo Nordisk A S Stock Forecast, Predictions & Price Target

1 week from now

Novo Nordisk (Ozempic) 's revenue in 2024 is $38,876,867,816. ... According to . 3 Wall Street analysts that have issued a 1 year NVO price target, the average NVO price target is $158.67, …

wallstreetzen.com

Novo Nordisk A (NVO) Price Target Increased By 6.93% To 119.21

1 week from now

The average one-year price target for Novo Nordisk A (NYSE:NVO) has been revised to 119.21 / share. This is an increase of 6.93% from the prior estimate of 111.49 dated January 18, 2024.

nasdaq.com

Novo Nordisk's Wegovy Weight-loss Drug Sales Beat Forecast, …

1 week from now

Nov 6, 2024  · Shares in Novo Nordisk , opens new tab, which competes with Eli Lilly , opens new tab in an obesity drug market that some analysts forecast could be worth about $150 billion by …

reuters.com

Novo Nordisk A/S (NYSE:NVO) Stock Price Down 4.2% - MarketBeat

1 week from now

1 day ago  · Cantor Fitzgerald reiterated an "overweight" rating and set a $160.00 price target on shares of Novo Nordisk A/S in a research note on Wednesday, November 6th. BMO Capital …

marketbeat.com

Where Will Novo Nordisk Stock Be In 5 Years? | The Motley Fool

1 week from now

Sep 22, 2023  · Through the first six months of this year, the company's net sales growth was 29% year over year with Novo Nordisk's top line totaling 107.7 billion Danish kroner ($15.1 billion). …

fool.com

Novo Nordisk A/S (NVO) Price Prediction And Forecast 2025-2030

1 week from now

2 days ago  · Their consensus 12-month target price for Novo Nordisk is $140.07, which is a 31.02% gain over today’s stock price. The 24/7 Wall Street 12-month projected target is a …

247wallst.com

Novo Nordisk: Outlook For Weight Loss Drugs In 2024 - Seeking …

1 week from now

Jan 22, 2024  · Novo Nordisk's weight loss drug, Wegovy, earned $1.38 billion last quarter. Click here to read my analysis of NVO stock and my recommendation.

seekingalpha.com

NVO - Novo Nordisk Adr Stock Price Forecast 2024, 2025, 2030 To …

1 week from now

6 days ago  · The Novo Nordisk Adr (NVO) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $151.29, representing a +37.33% increase …

stockscan.io

Here's Why Novo Nordisk (NVO) Is A Strong Growth Stock

1 week from now

4 days ago  · Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared …

nasdaq.com

This Is What Whales Are Betting On Novo Nordisk - Benzinga

1 week from now

2 days ago  · Investors with a lot of money to spend have taken a bullish stance on Novo Nordisk NVO. ... this stock with an average target price of $158.0. ... rating on Novo Nordisk, which …

benzinga.com

NVO Forecast — Price Target — Prediction For 2025 - TradingView

1 week from now

See Novo Nordisk A/S stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy. ... Price target. 143.22 0.00 0.00%. …

tradingview.com

Decoding Novo Nordisk's Options Activity: What's The Big Picture?

1 week from now

5 days ago  · Current Position of Novo Nordisk With a trading volume of 3,829,487, the price of NVO is up by 1.72%, reaching $109.05. Current RSI values indicate that the stock is may be …

nasdaq.com